into the motor cortex of a human patient in the US for the first time. Doctors in New York's Mount Sinai West did so as part of the company's COMMAND trial, which is aiming to examine the safety of Synchron's implant in patients with severe paralysis. The company also completed a study in Australia, wherein four people were determined to still be safe even after a year with its implant.
Like Neuralink, Synchron is also hoping to provide people with limited mobility the ability to control devices like smartphones and computers with their minds. That will give them the independence to email, text and do various digital tasks. Earlier this year, Max Hodak, the Neuralink co-founder who left the company in 2021,
that he took on an advisory role with Synchron. He also financially invested in the company"given [his] excitement for what they're doing." It's worth noting, though, that Musk reportedly held discussions with other Neuralink rivals in the past.says he also approached brain-machine interface developer Paradromics in 2020, but those talks were ultimately abandoned.
All products recommended by Engadget are selected by our editorial team, independent of our parent company. Some of our stories include affiliate links. If you buy something through one of these links, we may earn an affiliate commission.
steeling the inventions😂 so typical
My husband is an engineer with a brilliant potentially billion dollar energy invention that does not include the sun or wind but is just as clean is sustainable endless and unthought of
That of course would be a great investment. But investing in my husbands clean sustainable energy invention would also be a good investment
Ahhh shiiit…😂
Maybe he can buy a new brain instead of Twitter 🤣😂
FTC just waiting on standby at this point.
Equifax, Experian and Transunion all need to develop a new way to track and report these kinda frauds.
Didn't he kill enough monkeys already?
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
출처: MsMagazine - 🏆 378. / 59 더 많은 것을 읽으십시오 »